<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02838017</url>
  </required_header>
  <id_info>
    <org_study_id>EH16-095</org_study_id>
    <nct_id>NCT02838017</nct_id>
  </id_info>
  <brief_title>Tissue Adhesive vs. Sterile Strips After Cesarean Delivery</brief_title>
  <acronym>TASC</acronym>
  <official_title>Tissue Adhesive Compared to Sterile Strips After Cesarean Delivery: A Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>NorthShore University HealthSystem</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Chicago</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>NorthShore University HealthSystem</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal of this project is to identify a strategy to reduce wound complications in women who
      undergo cesarean delivery by Pfannenstiel skin incision. Currently, many Pfannenstiel skin
      incisions are closed by subcuticular sutures followed by either placement of sterile strips
      or tissue A\adhesive. Either sterile strips or tissue adhesive can be placed over the wound
      as a covering but it is unclear which may reduce wound complication rates. The hypothesis of
      this study is that tissue adhesive will result in a reduction in wound complication rates
      when compared to sterile strips. Previously published studies in non-obstetric populations
      have identified tissue adhesive as a potential intervention to reduce wound complications.
      The eligible population for this study will include women at NorthShore University
      HealthSystem Evanston Hospital and University of Chicago Hospital who will undergo primary or
      repeat cesarean delivery via Pfannenstiel skin incision. Women in the study will be
      randomized to receive either sterile strips or tissue adhesive. The primary outcome to be
      evaluated will be a composite of wound complication which will include drainage, cellulitis,
      hematoma, seroma and/or wound separation (partial or complete). Secondary endpoints to be
      investigated include cosmetic outcome, patient satisfaction, cost comparison, and difference
      in operative times.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Based on results of an interim analysis, the study was halted for futility
  </why_stopped>
  <start_date>November 2016</start_date>
  <completion_date type="Actual">June 2018</completion_date>
  <primary_completion_date type="Actual">June 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Participants With Wound Complication</measure>
    <time_frame>6-8 weeks from cesarean delivery</time_frame>
    <description>Wound drainage, Cellulitis, Abscess, Hematoma, Seroma or Separation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Readmission for Wound Complication</measure>
    <time_frame>Within 8 weeks from cesarean delivery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Satisfaction With Cesarean Scar</measure>
    <time_frame>6-8 weeks from cesarean delivery</time_frame>
    <description>The investigators will be using a modified validated Patient Scar Assessment Scale (PSAS) which assessed scar-related pain, itchiness, color, stiffness, irregularity and overall satisfaction with the scar. Each item on the PSAS has a 10-point scale, with 10 indicating the highest symptom severity or lowest satisfaction. The median score for each item was compared between groups.
Please see website in links section for more details on this assessment tool.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants Who Required an Office or Emergency Department Visit for Wound Complication</measure>
    <time_frame>Within 8 weeks of delivery</time_frame>
    <description>The investigators will review medical records to assess for ambulatory visits for wound complaints</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Operative Time</measure>
    <time_frame>At time of delivery</time_frame>
    <description>The investigators will review operative records to assess operative time</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants Requiring Antibiotic Treatment for Wound Complication</measure>
    <time_frame>Within 8 weeks of delivery</time_frame>
    <description>The investigators will review medical records to assess for antibiotic prescriptions for wound complications</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">504</enrollment>
  <condition>Wound Complication</condition>
  <condition>Complications; Cesarean Section</condition>
  <arm_group>
    <arm_group_label>Tissue Adhesive</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Tissue Adhesive will be placed over subcuticular suture closure.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Steri-Strips</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Sterile strips will be placed over subcuticular suture closure.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Tissue Adhesive</intervention_name>
    <arm_group_label>Tissue Adhesive</arm_group_label>
    <other_name>Dermabond</other_name>
    <other_name>Dermaflex</other_name>
    <other_name>2-octyl cyanoacrylate</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Sterile strips</intervention_name>
    <arm_group_label>Steri-Strips</arm_group_label>
    <other_name>Steri-Strips</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Women undergoing Pfannenstiel Cesarean delivery

        Exclusion Criteria:

          -  Inability to provide informed consent in English

          -  Planned use of staples for skin closure

          -  Unavailability of research personnel to accomplish consent and randomization at the
             time of cesarean
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Beth Plunkett, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>NorthShore University HealthSystem</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Lena Braginsky, MD</last_name>
    <role>Study Director</role>
    <affiliation>NorthShore University HealthSystem</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Chicago</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60637</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>NorthShore Evanston Hospital</name>
      <address>
        <city>Evanston</city>
        <state>Illinois</state>
        <zip>60201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>NorthShore Highland Park Hospital</name>
      <address>
        <city>Highland Park</city>
        <state>Illinois</state>
        <zip>60035</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Souza EC, Fitaroni RB, Januzelli DM, Macruz HM, Camacho JC, Souza MR. Use of 2-octyl cyanoacrylate for skin closure of sternal incisions in cardiac surgery: observations of microbial barrier effects. Curr Med Res Opin. 2008 Jan;24(1):151-5.</citation>
    <PMID>18034920</PMID>
  </reference>
  <reference>
    <citation>Mackeen AD, Packard RE, Ota E, Berghella V, Baxter JK. Timing of intravenous prophylactic antibiotics for preventing postpartum infectious morbidity in women undergoing cesarean delivery. Cochrane Database Syst Rev. 2014 Dec 5;(12):CD009516. doi: 10.1002/14651858.CD009516.pub2. Review.</citation>
    <PMID>25479008</PMID>
  </reference>
  <reference>
    <citation>Noorani A, Rabey N, Walsh SR, Davies RJ. Systematic review and meta-analysis of preoperative antisepsis with chlorhexidine versus povidone-iodine in clean-contaminated surgery. Br J Surg. 2010 Nov;97(11):1614-20. doi: 10.1002/bjs.7214. Review.</citation>
    <PMID>20878942</PMID>
  </reference>
  <reference>
    <citation>Stamilio DM, Scifres CM. Extreme obesity and postcesarean maternal complications. Obstet Gynecol. 2014 Aug;124(2 Pt 1):227-32. doi: 10.1097/AOG.0000000000000384. Erratum in: Obstet Gynecol. 2016 Sep;128(3):660.</citation>
    <PMID>25004353</PMID>
  </reference>
  <reference>
    <citation>Tipton AM, Cohen SA, Chelmow D. Wound infection in the obese pregnant woman. Semin Perinatol. 2011 Dec;35(6):345-9. doi: 10.1053/j.semperi.2011.05.020. Review.</citation>
    <PMID>22108085</PMID>
  </reference>
  <reference>
    <citation>Buresch AM, Van Arsdale A, Ferzli M, Sahasrabudhe N, Sun M, Bernstein J, Bernstein PS, Ngai IM, Garry DJ. Comparison of Subcuticular Suture Type for Skin Closure After Cesarean Delivery: A Randomized Controlled Trial. Obstet Gynecol. 2017 Sep;130(3):521-526. doi: 10.1097/AOG.0000000000002200.</citation>
    <PMID>28796687</PMID>
  </reference>
  <reference>
    <citation>Daykan Y, Sharon-Weiner M, Pasternak Y, Tzadikevitch-Geffen K, Markovitch O, Sukenik-Halevy R, Biron-Shental T. Skin closure at cesarean delivery, glue vs subcuticular sutures: a randomized controlled trial. Am J Obstet Gynecol. 2017 Apr;216(4):406.e1-406.e5. doi: 10.1016/j.ajog.2017.01.009. Epub 2017 Jan 30.</citation>
    <PMID>28153666</PMID>
  </reference>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>July 12, 2016</study_first_submitted>
  <study_first_submitted_qc>July 19, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 20, 2016</study_first_posted>
  <results_first_submitted>June 6, 2019</results_first_submitted>
  <results_first_submitted_qc>July 22, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">August 14, 2019</results_first_posted>
  <last_update_submitted>July 22, 2019</last_update_submitted>
  <last_update_submitted_qc>July 22, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 14, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>NorthShore University HealthSystem</investigator_affiliation>
    <investigator_full_name>Beth Plunkett</investigator_full_name>
    <investigator_title>Clinical Associate Professor, Maternal &amp; Fetal Medicine, Obstetrics &amp; Gynecology</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infertility</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>All of the individual participant data collected during the trial, after deidentiÔ¨Åcation, will be available upon request.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_info_type>Analytic Code</ipd_info_type>
    <ipd_time_frame>Available immediately after publication with no end date.</ipd_time_frame>
    <ipd_access_criteria>Investigators may request data by contacting lbraginsky@northshore.org</ipd_access_criteria>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>May 19, 2017</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/17/NCT02838017/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Tissue Adhesive</title>
          <description>Tissue Adhesive will be placed over subcuticular suture closure.
Tissue Adhesive</description>
        </group>
        <group group_id="P2">
          <title>Sterile Strips</title>
          <description>Sterile strips will be placed over subcuticular suture closure.
Sterile strips</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="252"/>
                <participants group_id="P2" count="252"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="238"/>
                <participants group_id="P2" count="241"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="14"/>
                <participants group_id="P2" count="11"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="14"/>
                <participants group_id="P2" count="11"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Tissue Adhesive</title>
          <description>Tissue Adhesive will be placed over subcuticular suture closure.
Tissue Adhesive</description>
        </group>
        <group group_id="B2">
          <title>Steri-Strips</title>
          <description>Sterile strips will be placed over subcuticular suture closure.
Sterile strips</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="252"/>
            <count group_id="B2" value="252"/>
            <count group_id="B3" value="504"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="34" lower_limit="30.0" upper_limit="36.0"/>
                    <measurement group_id="B2" value="33.5" lower_limit="29.0" upper_limit="36.0"/>
                    <measurement group_id="B3" value="34" lower_limit="29.0" upper_limit="36.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="252"/>
                    <measurement group_id="B2" value="252"/>
                    <measurement group_id="B3" value="504"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="30"/>
                    <measurement group_id="B2" value="28"/>
                    <measurement group_id="B3" value="58"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="191"/>
                    <measurement group_id="B2" value="204"/>
                    <measurement group_id="B3" value="395"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="31"/>
                    <measurement group_id="B2" value="20"/>
                    <measurement group_id="B3" value="51"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>White</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="121"/>
                    <measurement group_id="B2" value="139"/>
                    <measurement group_id="B3" value="260"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Black or African American</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="74"/>
                    <measurement group_id="B2" value="65"/>
                    <measurement group_id="B3" value="139"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Asian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="29"/>
                    <measurement group_id="B2" value="31"/>
                    <measurement group_id="B3" value="60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Other</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="31"/>
                    <measurement group_id="B2" value="20"/>
                    <measurement group_id="B3" value="51"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Nulliparity</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="25"/>
                    <measurement group_id="B2" value="25"/>
                    <measurement group_id="B3" value="50"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Prior cesarean delivery</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="144"/>
                    <measurement group_id="B2" value="140"/>
                    <measurement group_id="B3" value="284"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Body mass index at delivery</title>
          <units>kg/m^2</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="32.9" lower_limit="28.5" upper_limit="38.0"/>
                    <measurement group_id="B2" value="33.5" lower_limit="29.0" upper_limit="38.2"/>
                    <measurement group_id="B3" value="33.3" lower_limit="28.8" upper_limit="38.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Diabetes mellitus</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="30"/>
                    <measurement group_id="B2" value="44"/>
                    <measurement group_id="B3" value="74"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Hypertensive disorders</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="54"/>
                    <measurement group_id="B2" value="57"/>
                    <measurement group_id="B3" value="111"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Tobacco use</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Immunocompromised</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Cesarean delivery while in labor</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="64"/>
                    <measurement group_id="B2" value="56"/>
                    <measurement group_id="B3" value="120"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Chorioamnionitis</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Blood loss</title>
          <units>mL</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="700.0" lower_limit="494.8" upper_limit="903.8"/>
                    <measurement group_id="B2" value="745.0" lower_limit="525.0" upper_limit="994.0"/>
                    <measurement group_id="B3" value="700.0" lower_limit="502.8" upper_limit="945.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With Wound Complication</title>
        <description>Wound drainage, Cellulitis, Abscess, Hematoma, Seroma or Separation</description>
        <time_frame>6-8 weeks from cesarean delivery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Tissue Adhesive</title>
            <description>Tissue Adhesive will be placed over subcuticular suture closure.
Tissue Adhesive</description>
          </group>
          <group group_id="O2">
            <title>Sterile Strips</title>
            <description>Sterile strips will be placed over subcuticular suture closure.
Sterile strips</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Wound Complication</title>
          <description>Wound drainage, Cellulitis, Abscess, Hematoma, Seroma or Separation</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="238"/>
                <count group_id="O2" value="241"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18"/>
                    <measurement group_id="O2" value="19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Readmission for Wound Complication</title>
        <time_frame>Within 8 weeks from cesarean delivery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Tissue Adhesive</title>
            <description>Tissue Adhesive will be placed over subcuticular suture closure.
Tissue Adhesive</description>
          </group>
          <group group_id="O2">
            <title>Sterile Strips</title>
            <description>Sterile strips will be placed over subcuticular suture closure.
Sterile strips</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Readmission for Wound Complication</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="238"/>
                <count group_id="O2" value="241"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Satisfaction With Cesarean Scar</title>
        <description>The investigators will be using a modified validated Patient Scar Assessment Scale (PSAS) which assessed scar-related pain, itchiness, color, stiffness, irregularity and overall satisfaction with the scar. Each item on the PSAS has a 10-point scale, with 10 indicating the highest symptom severity or lowest satisfaction. The median score for each item was compared between groups.
Please see website in links section for more details on this assessment tool.</description>
        <time_frame>6-8 weeks from cesarean delivery</time_frame>
        <population>Completion of the modified Patient Scar Assessment Scale was accomplished in 203/252 (80.6%) of women in the tissue adhesive group and 203/252 (80.6%) of women in the sterile strips group.</population>
        <group_list>
          <group group_id="O1">
            <title>Tissue Adhesive</title>
            <description>Tissue Adhesive will be placed over subcuticular suture closure.
Tissue Adhesive</description>
          </group>
          <group group_id="O2">
            <title>Sterile Strips</title>
            <description>Sterile strips will be placed over subcuticular suture closure.
Sterile strips</description>
          </group>
        </group_list>
        <measure>
          <title>Satisfaction With Cesarean Scar</title>
          <description>The investigators will be using a modified validated Patient Scar Assessment Scale (PSAS) which assessed scar-related pain, itchiness, color, stiffness, irregularity and overall satisfaction with the scar. Each item on the PSAS has a 10-point scale, with 10 indicating the highest symptom severity or lowest satisfaction. The median score for each item was compared between groups.
Please see website in links section for more details on this assessment tool.</description>
          <population>Completion of the modified Patient Scar Assessment Scale was accomplished in 203/252 (80.6%) of women in the tissue adhesive group and 203/252 (80.6%) of women in the sterile strips group.</population>
          <units>score on a scale</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="203"/>
                <count group_id="O2" value="203"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1" lower_limit="1.0" upper_limit="3.0"/>
                    <measurement group_id="O2" value="2" lower_limit="1.0" upper_limit="4.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants Who Required an Office or Emergency Department Visit for Wound Complication</title>
        <description>The investigators will review medical records to assess for ambulatory visits for wound complaints</description>
        <time_frame>Within 8 weeks of delivery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Tissue Adhesive</title>
            <description>Tissue Adhesive will be placed over subcuticular suture closure.
Tissue Adhesive</description>
          </group>
          <group group_id="O2">
            <title>Sterile Strips</title>
            <description>Sterile strips will be placed over subcuticular suture closure.
Sterile strips</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Who Required an Office or Emergency Department Visit for Wound Complication</title>
          <description>The investigators will review medical records to assess for ambulatory visits for wound complaints</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="238"/>
                <count group_id="O2" value="241"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16"/>
                    <measurement group_id="O2" value="18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Operative Time</title>
        <description>The investigators will review operative records to assess operative time</description>
        <time_frame>At time of delivery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Tissue Adhesive</title>
            <description>Tissue Adhesive will be placed over subcuticular suture closure.
Tissue Adhesive</description>
          </group>
          <group group_id="O2">
            <title>Sterile Strips</title>
            <description>Sterile strips will be placed over subcuticular suture closure.
Sterile strips</description>
          </group>
        </group_list>
        <measure>
          <title>Operative Time</title>
          <description>The investigators will review operative records to assess operative time</description>
          <units>min</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="238"/>
                <count group_id="O2" value="241"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="58.5" lower_limit="48.0" upper_limit="70.3"/>
                    <measurement group_id="O2" value="60" lower_limit="51" upper_limit="72"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants Requiring Antibiotic Treatment for Wound Complication</title>
        <description>The investigators will review medical records to assess for antibiotic prescriptions for wound complications</description>
        <time_frame>Within 8 weeks of delivery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Tissue Adhesive</title>
            <description>Tissue Adhesive will be placed over subcuticular suture closure.
Tissue Adhesive</description>
          </group>
          <group group_id="O2">
            <title>Sterile Strips</title>
            <description>Sterile strips will be placed over subcuticular suture closure.
Sterile strips</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Requiring Antibiotic Treatment for Wound Complication</title>
          <description>The investigators will review medical records to assess for antibiotic prescriptions for wound complications</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="238"/>
                <count group_id="O2" value="241"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                    <measurement group_id="O2" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>8 weeks</time_frame>
      <desc>Patients were contacted and medical records reviewed to assess for adverse events</desc>
      <group_list>
        <group group_id="E1">
          <title>Tissue Adhesive</title>
          <description>Tissue Adhesive will be placed over subcuticular suture closure.
Tissue Adhesive</description>
        </group>
        <group group_id="E2">
          <title>Sterile Strips</title>
          <description>Sterile strips will be placed over subcuticular suture closure.
Sterile strips</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="252"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="252"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="252"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="252"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="252"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="252"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Lena Braginsky</name_or_title>
      <organization>NorthShore University HealthSystem</organization>
      <phone>2245952705</phone>
      <email>lena.braginsky.mfm@gmail.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

